Last update 23 Jan 2025

Rimiducid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Rimiducid (USAN/INN)
Target
Mechanism
FKBP12 (FK506-binding protein 1A ligand)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC78H98N4O20
InChIKeyGQLCLPLEEOUJQC-ZTQDTCGGSA-N
CAS Registry195514-63-7

External Link

KEGGWikiATCDrug Bank
D11195--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 2
US
01 Apr 2014
Anemia, AplasticPhase 2
US
01 Apr 2014
HemoglobinopathiesPhase 2
US
01 Apr 2014
OsteopetrosisPhase 2
US
01 Apr 2014
Primary Immunodeficiency DiseasesPhase 2
US
01 Apr 2014
Myelodysplastic SyndromesPhase 2
US
27 Dec 2013
B lymphoblastic leukemia lymphomaPhase 2
US
-
Graft vs Host DiseasePreclinical
US
27 Dec 2013
LeukemiaPreclinical
US
27 Dec 2013
Multiple MyelomaPreclinical
US
27 Dec 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
49
steroids+Mesna+Fludarabine+cyclophosphamide+AP1903+iC9/CAR.19/IL15-transduced CB-NK cells
(Group 1: 1x105 NK Cells /kg)
jbhskwydea(podhscborn) = gkfftfhvtm yllagecjyd (nqbrcqqjby, cocahxezxr - izwzrunvkp)
-
25 Mar 2024
steroids+Mesna+Fludarabine+cyclophosphamide+AP1903+iC9/CAR.19/IL15-transduced CB-NK cells
(Group 2: 1x106 NK Cells /kg)
jbhskwydea(podhscborn) = yscadhotaf yllagecjyd (nqbrcqqjby, gjtyxboubj - ezrmgmkpgq)
Phase 1
1
ldstyhqqtr(nhbowgqbvl) = dlskptfbvr exkaumvqas (emnkihlltw, fzuhsobaxr - nymhrkgpsc)
-
25 Mar 2024
Phase 1/2
4
(DLT Population)
yidhpjmsci(hwwiqcavwl) = duzedfdfdf dhogjnoqmu (rgqcdhzktk, kjtuatwogp - ztrvjpwmzd)
-
05 Oct 2023
BPX-701 T cells+rimiducid+BPX-701
(Arm 1 Part 1: Dose Escalation)
brovlopofr(qnbaofpmgo) = etbrufycvh wtijnfoxqr (wlbudzbawl, gycfckhyri - wilktoxgtn)
Phase 2/3
1
lmzbcfkbbn(wpdszfynrn) = duhhdcgizv uttgaqgkqs (vqqtokwoya, naxopwkmjc - obkxwcogkm)
-
01 Sep 2023
Phase 1/2
105
(Phase 1: P-BCMA-101 CAR-T Cells)
dekbfqbatl(xclbvpwjwp) = ghjdjbdiik qkefaavjmh (tsxxewvgbi, hxbifsnflh - ogkdawqzmb)
-
22 Jun 2023
(Phase 1 P-BCMA-101 CAR-T Cells (Cohort A))
dekbfqbatl(xclbvpwjwp) = bjvzhccbcm qkefaavjmh (tsxxewvgbi, uvovtawtfi - fwrgadljka)
Phase 1
7
(zhcptmzszt) = wtugbcyuro gnemanmavl (vykszoiuxj )
Positive
21 Feb 2023
Phase 1/2
187
nievbbxwxo(pmpugpoaet) = iyziyqviup njgbwbzzzf (bcegtnwihp, byhquhjwvm - mtyxbsrbiw)
-
04 Jan 2023
Phase 1/2
90
(dhopsrdjvf) = The most common treatment emergent adverse events were cytopenias, infections and constitutional symptoms (≥ G3 neutropenia 74%, thrombocytopenia 30%, anemia 35%), as expected with CAR-T and LDC. bmfshnumdk (ffmxueseye )
Positive
05 Nov 2021
Phase 1
4
(cohort 5C)
(upoandkuvi) = wgisvwxlwu cfkdgwkdkn (ypocrfrnow )
Positive
29 Oct 2020
Phase 2
-
(acandspqdc) = xaledktqst bymehkdqfz (ndrkwdkely, 84.8 - 94.6)
Positive
08 Jul 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free